S 932 · in committee · significant
Give Kids a Chance Act of 2025
- healthcare
What this bill does
- The bill allows clinical trials to test new cancer drugs combined with already-approved drugs for treating pediatric cancer.
- Pediatric cancer patients and pharmaceutical companies developing new treatments are affected.
- The bill renews FDA authority to award priority review vouchers to rare pediatric disease drug developers through 2029.
Generated by claude-haiku-4-5
Community Threads
Started by Cosponsor
- 01
How might allowing combination trials of new and approved cancer drugs change the speed at which pediatric patients can access potentially more effective treatments?
- 02
What trade-offs exist between giving pharmaceutical companies priority review vouchers and ensuring resources are allocated to the rarest pediatric cancers?
- 03
How would this bill's combination trial approach differ from current pediatric cancer drug development processes, and what evidence supports this new pathway?
Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.
Sponsor · R-OK
Markwayne Mullin
Citizen cosponsors
0
In Congress
20/ 100
Senators cosponsoring
Introduced 2025-03-11
Joining the bill
Michael F. Bennet
D-CO · original
Roger Marshall
R-KS
Amy Klobuchar
D-MN
Jeanne Shaheen
D-NH
Rick Scott
R-FL
Susan M. Collins
R-ME
Jon Husted
R-OH
Shelley Moore Capito
R-WV
Christopher A. Coons
D-DE
Mark Kelly
D-AZ
Tim Sheehy
R-MT
Andy Kim
D-NJ
+ 8 more
Legislative timeline
2025-03-11 · senate · IntroReferral
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
2025-03-11 · IntroReferral
Introduced in Senate
Citizen comments
Sign in to comment on this bill.
No comments yet — be the first.